Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults

Clinical trial NCT06033612 · COMPLETED

Trial details

NCT number: NCT06033612
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2021-11-12
Primary completion: 2022-07-27
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.